GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Operating income, FY2025
- £7.9B
- YoY, FY2025
- +97.3%
- 5-year CAGR
- +5.8%
- 10-year CAGR
- −2.6%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| FY2025 | £7.9B | +97.3% |
| FY2024 | £4.0B | −40.4% |
| FY2023 | £6.7B | +4.8% |
| FY2022 | £6.4B | +47.6% |
| FY2021 | £4.4B | −27.1% |
| FY2020 | £6.0B | −14.1% |
| FY2019 | £7.0B | +27.0% |
| FY2018 | £5.5B | +34.2% |
| FY2017 | £4.1B | +57.3% |
| FY2016 | £2.6B | −74.8% |
| FY2015 | £10.3B | — |